These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 30176511)
1. Recent insights into the development of nucleic acid-based nanoparticles for tumor-targeted drug delivery. Buddolla AL; Kim S Colloids Surf B Biointerfaces; 2018 Dec; 172():315-322. PubMed ID: 30176511 [TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
3. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors. Castillo RR; Baeza A; Vallet-Regí M Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473 [TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
5. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise. Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799 [TBL] [Abstract][Full Text] [Related]
6. Engineering DNA scaffolds for delivery of anticancer therapeutics. Sun W; Gu Z Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936 [TBL] [Abstract][Full Text] [Related]
8. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review. Kamath PR; Sunil D Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780 [TBL] [Abstract][Full Text] [Related]
9. Chitosan-based nanoparticles for tumor-targeted drug delivery. Prabaharan M Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550 [TBL] [Abstract][Full Text] [Related]
11. Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment. Obeid MA; Aljabali AAA; Rezigue M; Amawi H; Alyamani H; Abdeljaber SN; Ferro VA Methods Mol Biol; 2021; 2265():591-620. PubMed ID: 33704742 [TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment. Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588 [TBL] [Abstract][Full Text] [Related]
13. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs. Huang W; Chen L; Kang L; Jin M; Sun P; Xin X; Gao Z; Bae YH Adv Drug Deliv Rev; 2017 Jun; 115():82-97. PubMed ID: 28624478 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticles and targeted drug delivery in cancer therapy. Bahrami B; Hojjat-Farsangi M; Mohammadi H; Anvari E; Ghalamfarsa G; Yousefi M; Jadidi-Niaragh F Immunol Lett; 2017 Oct; 190():64-83. PubMed ID: 28760499 [TBL] [Abstract][Full Text] [Related]
15. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. Chen C; Yang Z; Tang X Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675 [TBL] [Abstract][Full Text] [Related]
16. Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery. Vaughan HJ; Green JJ; Tzeng SY Adv Mater; 2020 Apr; 32(13):e1901081. PubMed ID: 31222852 [TBL] [Abstract][Full Text] [Related]
17. Protein-based nanoparticles for therapeutic nucleic acid delivery. Eweje F; Walsh ML; Ahmad K; Ibrahim V; Alrefai A; Chen J; Chaikof EL Biomaterials; 2024 Mar; 305():122464. PubMed ID: 38181574 [TBL] [Abstract][Full Text] [Related]
18. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bartlett DW; Davis ME Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672 [TBL] [Abstract][Full Text] [Related]
19. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
20. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors. Iyer AK; Duan Z; Amiji MM Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]